All companies › WST

WST · WEST PHARMACEUTICAL SERVICES INC

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells6
Research cases0
Last filing2026-09-15

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-08 — Favorite Annette F · sold 2,500 @ $340.81 2026-09-08 — Favorite Annette F · sold 2,817 @ $340.81 2026-09-08 — Favorite Annette F · sold 2,818 @ $340.81 2026-09-11 — Favorite Annette F · sold 2,500 @ $345.00 2026-09-14 — Favorite Annette F · sold 2,500 @ $355.00 2026-09-15 — Favorite Annette F · sold 2,524 @ $365.00
2026-09-082026-09-15

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Favorite Annette F Sr. VP & Chief HR Officer
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $WST is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-09-15', 'insider_name': 'Favorite Annette F', 'insider_title': 'Sr. VP & Chief HR Officer', 'transaction_type': 'Open-market sell', 'shares': 2524.0, 'price': 365.0, 'value': 921260.0, 'is_buy': False}, {'transaction_date': '2026-09-14', 'insider_name': 'Favorite Annette F', 'insider_title': 'Sr. VP & Chief HR Officer', 'transaction_type': 'Open-market sell', 'shares': 2500.0, 'price': 355.0, 'value': 887500.0, 'is_buy': False}, {'transaction_date': '2026-09-11', 'insider_name': 'Favorite Annette F', 'insider_title': 'Sr. VP & Chief HR Officer', 'transaction_type': 'Open-market sell', 'shares': 2500.0, 'price': 345.0, 'value': 862500.0, 'is_buy': False}, {'transaction_date': '2026-09-08', 'insider_name': 'Favorite Annette F', 'insider_title': 'Sr. VP & Chief HR Officer', 'transaction_type': 'Open-market sell', 'shares': 2500.0, 'price': 340.81, 'value': 852025.0, 'is_buy': False}, {'transaction_date': '2026-09-08', 'insider_name': 'Favorite Annette F', 'insider_title': 'Sr. VP & Chief HR Officer', 'transaction_type': 'Open-market sell', 'shares': 2817.0, 'price': 340.81, 'value': 960061.77, 'is_buy': False}, {'transaction_date': '2026-09-08', 'insider_name': 'Favorite Annette F', 'insider_title': 'Sr. VP & Chief HR Officer', 'transaction_type': 'Open-market sell', 'shares': 2818.0, 'price': 340.81, 'value': 960402.58, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for WST today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.